Cardiff Oncology Inc Strategic Asset Allocation Index
Cardiff Oncology Inc strategic asset allocation index. Cardiff Oncology Inc (CRDF) has a Strategic Asset Allocation Index of 1.6% as of June 2023. Strategic assets (PP&E of $1.36 Million plus long-term investments of $-) total $1.36 Million, measured against net assets of $86.58 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Cardiff Oncology Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cardiff Oncology Inc (2013–2022)
Strategic asset allocation index of Cardiff Oncology Inc from 2013 to 2022. This chart shows how Cardiff Oncology Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 1.6%, representing strategic assets of $1.36 Million against net assets of $86.58 Million USD. Check Cardiff Oncology Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Cardiff Oncology Inc Strategic Asset Allocation Index by Year (2013–2022)
Cardiff Oncology Inc strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Cardiff Oncology Inc from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CRDF market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.2% | $1.27 Million | $1.27 Million | $- | $106.34 Million | ▲ +0.9 pp |
| 2021 | 0.3% | $382.00K | $382.00K | $- | $140.42 Million | ▼ -0.2 pp |
| 2020 | 0.5% | $623.69K | $623.69K | $- | $128.16 Million | ▼ -11.5 pp |
| 2019 | 12.0% | $877.82K | $877.82K | $- | $7.31 Million | ▼ -0.9 pp |
| 2018 | 12.9% | $1.30 Million | $1.30 Million | $- | $10.08 Million | ▼ -24.4 pp |
| 2017 | 37.3% | $2.43 Million | $2.43 Million | $- | $6.51 Million | ▲ +17.9 pp |
| 2016 | 19.4% | $3.83 Million | $3.83 Million | $- | $19.77 Million | ▲ +13.8 pp |
| 2015 | 5.5% | $2.69 Million | $2.69 Million | $- | $48.70 Million | ▼ -4.5 pp |
| 2014 | 10.1% | $840.39K | $840.39K | $- | $8.35 Million | ▲ +6.4 pp |
| 2013 | 3.7% | $750.57K | $750.57K | $- | $20.39 Million | — |